Skip To Content
Cross Icon
SamaCare is named to Fast Company's Most Innovative Companies List.
Read more
samacare for life sciences

Never Lose a Patient to Preventable Administrative Errors

Prevent non-starts and discontinuations with real-time medical benefit prior authorization insights and AI-enabled support embedded directly into specialty practice workflows.

84%
Faster
31k+
Providers
2m+
Prior Authorizations

Understand Patient Access Friction. Intervene in Real-Time. Measure the Impact.

SamaCare combines real-time medical benefit prior authorization intelligence with AI-enabled in-workflow support, creating a closed loop system for understanding and reducing patient access barriers for Enhanced Brands.

Discover

Real-Time Access Intelligence

Gain visibility into barriers to therapy across medical benefit prior authorization for your drug:

  • Approval and denial trends
  • Time to resolution
  • Reasons for denial
  • Payer policy changes and enforcement patterns
  • Benchmarks by payer, plan, site of care, and competitive set
Schedule a Call
Image Description
Act

AI-Enabled In-Workflow Support

Deploy targeted support directly in specialty practice workflows, before access friction leads to patient churn:

  • Pre-submission policy intelligence designed to stop preventable denials
  • Documentation and submission guidance
  • Intelligent post-submission follow-up and human-in-the-loop escalation processes
Schedule a Call
Measure

Closed-Loop Impact

Measure the impact of sponsored support services at driving the market access outcomes that matter: 

  • Improved net approval rates
  • Reduced time to resolution
  • Increased patient starts
  • Reduced churn
Schedule a Call
Life sciences lineWave lines

Built on the Largest Real-Time Dataset in Medical Benefit Prior Authorization

SamaCare operates the most comprehensive, real-world dataset in medical benefit prior authorization.

29%
 ↑

Enhanced Brands sponsored on the platform see a 29% lift in PA approval rate compared to non-sponsored brands.

$
6
B+

$6.2B+ in annual medical benefit drug spend.

8
+ Years

8+ years embedded in specialty practice workflows.

Coverage

Coverage across drugs, payers, plans, and sites of care.

Structured and Continuously Refined

Using advanced AI techniques, SamaCare transforms messy payer data into actionable intelligence, without removing human expertise from the process.

Designed for High-Impact Access Moments

Achieve your market access goals with visibility on-the-ground and a direct support channel to providers nationwide.

Image Description

Gain Faster Visibility into Access Hurdles

Move from retrospective reporting to proactive access management.

Image Description

Respond to Competitive Access Pressure

Monitor how payer behavior shifts when new competitors enter the market, and act quickly to protect access experience.

Image Description

Monitor Access for New Therapy Launch

Identify early access barriers and deploy support immediately to accelerate patient starts.

Image Description

Improve Net Approval Rates

Surface payer friction in real-time and guide submissions towards higher first-pass success.

Image Description

Reduce Patient Drop-Off

Detect delays before they become denials and intervene before patients churn.

Image Description

Support Strategic Sites of Care

Deliver tailored support to targeted practice segments, including high-growth infusion settings.

Image Description

Deliver Provider Support at Scale

Deploy one-to-many in-workflow interventions with measurable lift.

Trusted for Medical Benefit Prior Authorizations Across the Healthcare Ecosystem

weinfuse
specialty networks
arn
neuronet gpo
nica
Life sciences lineWave lines

40% of Leading Global Pharmaceutical Companies Sponsor Their Brands on SamaCare

Icon

Comprehensive Dataset

Prior authorization outcomes, provider workflow signals, payer policy changes, observed enforcement patterns, and intervention data.

Icon

Proven Scale

8+ years of workflow software, millions of lifetime prior authorizations resolved, $6.2B in buy-and-bill PA volume (2025). 

Icon

Strategic Coverage

Significant presence across the specialties that use medical benefit drugs, like neurology, retina, oncology, rheumatology, and ambulatory infusion centers in the US.

Icon

Industry Adoption

40% of the leading global pharmaceutical companies sponsor their brands on SamaCare to improve patient access. 

Icon

Ecosystem Adoption

Seamless integration with major platforms and partners, including McKesson, Cencora, WeInfuse, and more.

Icon

Best-in-Class Humans + AI

Human PA expertise paired with AI to keep intelligence grounded in real-world practice.

Improve Patient Access, Provider Experience, and Brand Success

Access does not fail in theory. It fails in practice.

SamaCare operates at the point where medical benefit prior authorization determines whether patients start and stay on therapy — and provides the intelligence and intervention needed to ensure they do.

Resources for Market Access Champions

Life sciences lineWave lines
Article
SamaCare Named to Fast Company’s 2026 Most Innovative Companies List — and What That Recognition Really Means
Access
Article
The Road to Care Episode 11: Pharma Leaders Roundtable, Global Perspectives on Value and Access
Access
Article
Exclusive Report: MS DMT Market Access Insights
Access
Article
Get Early Access: Exclusive MS Patient Access Insights
Access
Article
The Road to Care™ Podcast Episode 4: Democratizing Pharmaceutical Research with Ex-Novartis US CSO Scott Howell
Access
Article
Introducing The Road to Care™ Podcast: a Healthcare Podcast for Patient Care Stakeholders
Access
Article
Overcoming Hidden Obstacles in the Script-to-Therapy Journey
Access
Article
SamaCare Secures $17M Series B Investment to Scale Specialty Drug Prior Authorization Platform
Access
Survey
Specialty Provider Market Access Survey
Access
Article
The prior authorization “monkey-in-the-middle” dilemma
Access
Article
If a prior authorization request gets approved, can it still harm patient care?
Access
resource
See all SamaCare Resources
Access
Back To Top